NovaBridge Biosciences Proceeds from Issuance of Common Limited Partners Units
NovaBridge Biosciences (NBP) reported Proceeds from Issuance of Common Limited Partners Units of CNY 8.55 million for the 12-month period ending 2021-12-31, per its 20-F filed 2024-04-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonLimitedPartnersUnits · last filed 2024-04-30
CNY
| Period end | Proceeds from Issuance of Common Limited Partners Units 6 month | Proceeds from Issuance of Common Limited Partners Units 12 month |
|---|---|---|
| 2021-12-31 | 8.55M CNY 20-F · filed 2024-04-30 | |
| 2021-06-30 | 3.11M CNY 6-K · filed 2022-11-10 | |
| 2020-12-31 | 46.00K CNY 20-F · filed 2023-05-01 |
USD
| Period end | Proceeds from Issuance of Common Limited Partners Units 12 month |
|---|---|
| 2021-12-31 | $1.34M 20-F · filed 2022-04-29 |
| 2020-12-31 | $7.00K 20-F · filed 2021-04-28 |